NCT03167268 2021-09-09
PaSTo
Ospedale San Carlo Borromeo
Phase 2 Unknown
Clinical Trials
11 trialsNCT01882985 2021-01-05
Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients
University of California, Irvine
Phase 2 Completed
NCT01443026 2019-11-19
The Effects of Lycopene on High Risk Prostatic Tissue
University of Illinois at Chicago
Phase 2 Completed
NCT00744549 2018-02-14
Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance
University Health Network, Toronto
Phase 2 Completed
NCT01105338 2018-01-23
ProDiet
University of Bristol
Phase 2/3 Completed
NCT00844792 2017-10-26
Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer
University Health Network, Toronto
Phase 2 Completed
NCT00669656 2017-04-20
Herbal Therapy for Treatment of Recurrent Prostate Cancer
University of Southern California
Phase 2 Completed
NCT00068731 2016-07-13
Lycopene in Treating Patients With Metastatic Prostate Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00178113 2015-05-27
A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia
University of Pittsburgh
Phase 1 Completed
NCT00042731 2012-09-24
Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT00172367 2008-09-26
Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma
National Taiwan University Hospital
Phase 2 Withdrawn